查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604579

抗寄生虫药市场：按药物类型、剂型、适应症、分销管道、最终用户划分 - 2025-2030 年全球预测

Antiparasitic Drugs Market by Drug Type (Anthelmintics, Antiprotozoals, Ectoparasiticides), Form (Injections, Oral Tablets/Capsules, Topical Creams), Indication, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年抗寄生虫药物市值为204亿美元，预计到2024年将达到211.2亿美元，复合年增长率为4.59%，到2030年将达到279.4亿美元。

抗寄生虫药物对于人类和动物寄生虫感染疾病的管理至关重要，并且在全球健康中发挥重要作用。这些治疗剂的范围从频谱药物到针对特定寄生虫（如蠕虫、原生动物和体外寄生虫）的药物，在治疗和预防保健中发挥着至关重要的作用。疟疾、利什曼原虫症和血吸虫病等疾病的流行证明了对这些药物的需求，特别是在热带地区。最终用途广泛，包括医院、诊所、製药公司和农业部门。市场开拓的驱动力是意识的提高、医疗成本的上升以及药物开发技术的进步。对新型疗法的需求，包括植物来源抗寄生虫药物和解决抗药性的下一代製剂，创造了显着的机会。此外，由于畜牧业生产和宠物养殖活性化，兽用抗寄生虫药领域的重要性迅速增加，也提供了良好的前景。

主要市场统计
基准年[2023] 204亿美元
预测年份 [2024] 211.2亿美元
预测年份 [2030] 279.4亿美元
复合年增长率（%） 4.59%

然而，该领域面临严格的法规环境、某些抗寄生虫药物的潜在副作用以及在偏远地区分发药物的困难等限制。寄生虫抗药性的快速发展也是一个重大挑战，需要持续的技术创新和研究。开创性的研究领域包括开发合成大麻素作为抗寄生虫药物、探索传统药用植物以及增强递送系统（例如基于奈米颗粒的药物载体）以提高功效并降低抗药性风险。製药公司、研究机构和全球卫生组织之间的合作对于解决这些障碍至关重要。

简而言之，抗寄生虫药物市场是一个充满活力的市场，既具有强劲的成长潜力，也面临多方面的挑战。希望利用目前商机的相关人员应专注于改进配方、改进诊断工具以及利用伙伴关係关係来渗透市场。随着该领域的发展，平衡创新和可近性对于最大限度地提高对全球健康和市场永续性的影响仍然至关重要。

市场动态：揭示快速发展的抗寄生虫药物市场的关键市场洞察

供需的动态交互作用正在改变抗寄生虫药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球寄生虫感染疾病的发生率和认识不断提高
    • 政府对寄生虫感染控制采取有利的措施
    • 加大研发投入
  • 市场限制因素
    • 药物研发需要庞大资金
  • 市场机会
    • 多个监管机构核准的抗寄生虫药物迅速增加
    • 製造商推出新的抗寄生虫药
  • 市场挑战
    • 与药物相关的副作用和风险

波特的五力：驾驭抗寄生虫药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解抗寄生虫药物市场的外部影响

外部宏观环境因素在塑造抗寄生虫药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解抗寄生虫药市场的竞争状况

抗寄生虫药市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵抗寄生虫药物市场供应商绩效评估

FPNV定位矩阵是评估抗寄生虫药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘抗寄生虫药物市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，抗寄生虫药市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球寄生虫感染的发生率和认识增加
      • 政府首选的寄生虫感染控制方法
      • 增加对研发活动的投资
    • 抑制因素
      • 药物研发需要大量资金
    • 机会
      • 多个监管机构核准的抗寄生虫药物激增
      • 厂商介绍新型抗寄生虫药
    • 任务
      • 与药物相关的副作用和风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按类型分類的抗寄生虫药市场

  • 驱虫药
  • 抗原虫
  • 外寄生虫剂
  • 寄生剂

第七章抗寄生虫药市场：依形式

  • 注射
  • 口服锭剂/胶囊
  • 外用霜

第八章以适应症分類的抗寄生虫药市场

  • 凿
  • 肠道寄生虫
  • 蝨子
  • 疟疾
  • 疥疮
  • 打钩

第九章抗寄生虫药市场：依通路

  • 离线
  • 在线的

第十章抗寄生虫药市场：依最终用户分类

  • 居家护理设施
  • 医院/诊所
  • 兽医诊所

第十一章美洲抗寄生虫药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太抗寄生虫药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲抗寄生虫药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Adva Care Pharma
  • Algen Healthcare Ltd.
  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Ben Pharmaceuticals
  • Centurion Laboratories Private Limited
  • Cipla Ltd.
  • Consern Pharma Limited
  • Dr.Reddys Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Fredun Group
  • Garcia Life Sciences
  • Glaxosmithkline PLC
  • Healthy Life Pharma Private Limited
  • Ipca Laboratories
  • Jackson Laboratories Pvt Ltd.
  • Mankind Pharma
  • Merck KgaA
  • Novartis AG
  • Sanofi
  • Soigner Pharma by Arlak Biotech
  • Sriwalls Health Care
  • Taj Life Sciences Pvt. Ltd.
  • Weefsel Pharma
  • Zydus Group
Product Code: MRR-B16853777759

The Antiparasitic Drugs Market was valued at USD 20.40 billion in 2023, expected to reach USD 21.12 billion in 2024, and is projected to grow at a CAGR of 4.59%, to USD 27.94 billion by 2030.

Antiparasitic drugs, essential in managing parasitic infections in humans and animals, serve a critical role in global health. These medications range from broad-spectrum agents to those targeting specific parasites like helminths, protozoa, or ectoparasites, and are pivotal in both treatment and preventive healthcare. The necessity of these drugs is underscored by the high prevalence of diseases like malaria, leishmaniasis, and schistosomiasis, particularly in tropical regions. Applications span human and veterinary medicine, with end-use scope encompassing hospitals, clinics, pharmaceutical enterprises, and agrarian sectors. Market growth is driven by increased awareness, rising healthcare expenditure, and advances in drug development technologies. Notable opportunities arise from the demand for novel therapeutics, including plant-based antiparasitics and next-generation formulations addressing drug resistance. The burgeoning importance of the veterinary antiparasitic segment, precipitated by intensified livestock production and pet ownership, also presents lucrative prospects.

KEY MARKET STATISTICS
Base Year [2023] USD 20.40 billion
Estimated Year [2024] USD 21.12 billion
Forecast Year [2030] USD 27.94 billion
CAGR (%) 4.59%

However, the field faces constraints such as stringent regulatory environments, potential side effects of certain antiparasitic agents, and difficulties in drug distribution in remote areas. The rapid pace of drug resistance among parasites poses a significant challenge, necessitating continuous innovation and research. Pioneering areas for research include the development of synthetic cannabinoids as antiparasitics, exploration of traditional medicinal plants, and the enhancement of delivery systems like nanoparticle-based drug carriers to increase efficacy and reduce resistance risks. Collaborative efforts among pharmaceutical companies, research institutions, and international health organizations are imperative to address these hurdles.

In essence, the antiparasitic drugs market is dynamic, characterized by both robust growth potential and multifaceted challenges. Stakeholders seeking to capitalize on current opportunities should focus on advancing drug formulations, improving diagnostic tools, and leveraging partnerships for enhanced market penetration. As the field evolves, it remains crucial to balance innovation with accessibility to maximize impact on global health and market sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antiparasitic Drugs Market

The Antiparasitic Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence and awareness of parasite infection across the globe
    • Favorable government initiatives for parasite infection management
    • Increasing investment in research and development activities
  • Market Restraints
    • Requirement of huge capital for drug development
  • Market Opportunities
    • Surge in approvals for antiparasitic drugs from several regulatory authorities
    • Introduction of novel antiparasitic drugs by manufacturers
  • Market Challenges
    • Adverse effects and risks associated with the drugs

Porter's Five Forces: A Strategic Tool for Navigating the Antiparasitic Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antiparasitic Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antiparasitic Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antiparasitic Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antiparasitic Drugs Market

A detailed market share analysis in the Antiparasitic Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antiparasitic Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antiparasitic Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antiparasitic Drugs Market

A strategic analysis of the Antiparasitic Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antiparasitic Drugs Market, highlighting leading vendors and their innovative profiles. These include Adva Care Pharma, Algen Healthcare Ltd., Amneal Pharmaceuticals LLC, Bayer AG, Ben Pharmaceuticals, Centurion Laboratories Private Limited, Cipla Ltd., Consern Pharma Limited, Dr.Reddys Laboratories Inc., F. Hoffmann-La Roche AG, Fredun Group, Garcia Life Sciences, Glaxosmithkline PLC, Healthy Life Pharma Private Limited, Ipca Laboratories, Jackson Laboratories Pvt Ltd., Mankind Pharma, Merck KgaA, Novartis AG, Sanofi, Soigner Pharma by Arlak Biotech, Sriwalls Health Care, Taj Life Sciences Pvt. Ltd., Weefsel Pharma, and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Antiparasitic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Anthelmintics, Antiprotozoals, Ectoparasiticides, and Endoparaciticides.
  • Based on Form, market is studied across Injections, Oral Tablets/Capsules, and Topical Creams.
  • Based on Indication, market is studied across Fleas, Intestinal Parasites, Lice, Malaria, Scabies, and Ticks.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-User, market is studied across Home Care Facilities, Hospitals & Clinics, and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence and awareness of parasite infection across the globe
      • 5.1.1.2. Favorable government initiatives for parasite infection management
      • 5.1.1.3. Increasing investment in research and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of huge capital for drug development
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals for antiparasitic drugs from several regulatory authorities
      • 5.1.3.2. Introduction of novel antiparasitic drugs by manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects and risks associated with the drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antiparasitic Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Anthelmintics
  • 6.3. Antiprotozoals
  • 6.4. Ectoparasiticides
  • 6.5. Endoparaciticides

7. Antiparasitic Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral Tablets/Capsules
  • 7.4. Topical Creams

8. Antiparasitic Drugs Market, by Indication

  • 8.1. Introduction
  • 8.2. Fleas
  • 8.3. Intestinal Parasites
  • 8.4. Lice
  • 8.5. Malaria
  • 8.6. Scabies
  • 8.7. Ticks

9. Antiparasitic Drugs Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Antiparasitic Drugs Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care Facilities
  • 10.3. Hospitals & Clinics
  • 10.4. Veterinary Clinics

11. Americas Antiparasitic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antiparasitic Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antiparasitic Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adva Care Pharma
  • 2. Algen Healthcare Ltd.
  • 3. Amneal Pharmaceuticals LLC
  • 4. Bayer AG
  • 5. Ben Pharmaceuticals
  • 6. Centurion Laboratories Private Limited
  • 7. Cipla Ltd.
  • 8. Consern Pharma Limited
  • 9. Dr.Reddys Laboratories Inc.
  • 10. F. Hoffmann-La Roche AG
  • 11. Fredun Group
  • 12. Garcia Life Sciences
  • 13. Glaxosmithkline PLC
  • 14. Healthy Life Pharma Private Limited
  • 15. Ipca Laboratories
  • 16. Jackson Laboratories Pvt Ltd.
  • 17. Mankind Pharma
  • 18. Merck KgaA
  • 19. Novartis AG
  • 20. Sanofi
  • 21. Soigner Pharma by Arlak Biotech
  • 22. Sriwalls Health Care
  • 23. Taj Life Sciences Pvt. Ltd.
  • 24. Weefsel Pharma
  • 25. Zydus Group

LIST OF FIGURES

  • FIGURE 1. ANTIPARASITIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPARASITIC DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIPARASITIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPARASITIC DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ENDOPARACITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY TOPICAL CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FLEAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY TICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023